Clinical Trials
53 trialsWondercel-UWD3
Wondercel Biotech (ShenZhen)
Stereotactic Body Radiation Therapy Followed by Surgery in Treating Patients With Stage I-IIIA Non-small Cell Lung Cancer
Roswell Park Cancer Institute
Genomically Guided Radiation Dose Personalization in Locally Advanced NSCLC
H. Lee Moffitt Cancer Center and Research Institute
TILs Plus Third-Generation EGFR-TKI Therapy for TKI-Resistant NSCLC
Tianjin Medical University General Hospital
A Vaccine (CIMAvax-EGF) for the Prevention of Lung Cancer Development or Recurrence
Roswell Park Cancer Institute
177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors
Radiopharm Theranostics, Ltd
Low-Dose Interleukin-2 and Pembrolizumab for the Treatment of Stage IV Non-Small Cell Lung Cancer
Emory University
Autologous CAR T-Cells Targeting the GD2 Antigen for Lung Cancer
UNC Lineberger Comprehensive Cancer Center
AKIR001
Karolinska University Hospital
Microlyvaqâ„¢
Biogenea Pharmaceuticals Ltd.
Feasibility Study of Personalized Ultra-fractionated Stereotactic Ablative Radiotherapy (PULSAR) for Cancers of the Central Lung
University of Texas Southwestern Medical Center
Ruxolitinib for Cancer Cachexia
University of Texas Southwestern Medical Center
[18F]F-AraG/Total Body PET Imaging and Healthy Subjects and Lung Cancer Patients
University of California, Davis
PORT
Rutgers, The State University of New Jersey
CSF CTC-Capture-Guided EGFR-TKI and Bevacizumab Combination Therapy in EGFR-Mutant Advanced NSCLC
Second Affiliated Hospital of Nanchang University
Study of CXCR5 Modified EGFR Targeted CAR-T Cells for Advanced NSCLC
Second Affiliated Hospital of Guangzhou Medical University
An Exploratory Study of Efficacy and Safety of Iruplinalkib Tablets in Patients With ROS1 Positive Non-small Cell Lung Cancer
Henan Cancer Hospital
99mTc/68Ga Labeled Anti-PD-L1 sdAb in Assessment of PD-L1 Expression in NSCLC
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
State University of New York - Upstate Medical University
Proton Based Cardiac Sparing Accelerated Fractionated RadioTherapy in Unresectable NSCLC
Case Comprehensive Cancer Center
Biodistribution and Safety of the PET Probes [18F]FPRGD2 and [18F]FPPRGD2
Stanford University
High Dose Vitamin A Compound in Treating Participants With Resectable Non-Small Cell Lung Cancer
Wake Forest University Health Sciences
A Phase 1 Study to Evaluate Paclitaxel Conjugated CXC Receptor 4 Antagonist (MB1707) in Patients With Advanced Cancer
Mainline Biosciences, Inc.
Breathe Easier
University of South Carolina
ALLIES
Nutricia Research
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors
Shanghai Yunying Medical Technology
OSIBOOST
Academisch Ziekenhuis Maastricht
Stereotactic Body Radiation Therapy After Surgery in Treating Patients With Stage III-IV Non-small Cell Lung Cancer
Roswell Park Cancer Institute
[18F]-AraG for the Detection of T-Cell Activation in Advanced Non-small Cell Lung Cancer Patients Undergoing PD-1/PD-L1-Directed Therapy
University of California, Davis
UCDCC#270: Avelumab and Stereotactic Ablative Radiotherapy in Non-responding and Progressing NSCLC Patients
University of California, Davis
Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients
Wake Forest University Health Sciences
An Exploratory Clinical Study of TILs in the Treatment of Recurrent / Refractory Non-small Cell Lung Cancer (NSCLC)
Shanghai OriginCell Therapeutics Co., Ltd.
Neoadjuvant Itraconazole in Non-small Cell Lung Cancer
University of Texas Southwestern Medical Center
Novel Light Delivery Methods for Lung Cancer Photodynamic Therapy - A Pilot Study
Taoyuan General Hospital
αPD1-MSLN-CAR T Cells for the Treatment of MSLN-positive Advanced Solid Tumors
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
UCDCC#269: A Pilot Study of Interlesional IL-2 and RT in Patients With NSCLC.
University of California, Davis
Pembrolizumab After Lung SBRT for Medically Inoperable Early Stage Non-small Cell Lung Cancer
Case Comprehensive Cancer Center
NO3DEXPL
Nilogen Oncosystems
Low-Dose Acetylsalicylic Acid in Treating Patients With Stage I-III Non-Small Cell Lung Cancer
Vanderbilt-Ingram Cancer Center
Amatuximab for High Mesothelin Cancers
National Institutes of Health Clinical Center (CC)
ATOM
University of Oxford
TITAN
Hoffmann-La Roche
PET Quantitative Assessments of Solid Tumor Response to Immune Checkpoint Blockade Therapy
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
A Pilot Study of MPDL3280A and HIGRT in Metastatic NSCLC
University of Michigan Rogel Cancer Center
Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Clinical Study of Microdosing Carboplatin in Lung or Bladder Cancer
University of California, Davis
Zeushield Cytotoxic T Lymphocytes (Z-CTLs) for Relapsed or Refractory Non Small Cell Lung Cancer (NSCLC)
Second Xiangya Hospital of Central South University
Feasibility Study of SBRT Plus Chemotherapy for Non-Small Cell Lung Carcinoma
Case Comprehensive Cancer Center
Stereotactic Radiosurgery and Systemic Dose Chemotherapy for Locally Advanced Lung Cancer
The Cooper Health System
Mature Dendritic Cell Vaccination Against Unique Immunogenic Peptides in Patients With Non Small Cell Lung Cancer (NSCLC)
Washington University School of Medicine